Skip to main content
. 2023 Oct 30;66(21):14787–14814. doi: 10.1021/acs.jmedchem.3c01385

Figure 3.

Figure 3

Design of dual Sirt2/HDAC6 inhibitors with merged or linked pharmacophores.